** Shares of infusion therapy services provider Option Care Health OPCH.O rise 2.03% to $33.3 premarket
** Co forecasts 2025 revenue in the range of $5.3 bln to $5.5 bln and profit between $1.59 to $1.69/share, higher than analysts' estimate of $5.26 bln and $1.25/share, respectively, as per data compiled by LSEG
** Co posts Q4 revenue of $1.35 bln, beating analyst estimates of $1.29 bln
** Co reports Q4 profit of 35 cents/share, vs analyst est of 34 cents/share
** Stock has risen 4.3% in the past 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。